Dr Garcia reports stocks from Invitae as an employee and stocks from 10x Genomics, Personalis, and 23andMe from previous employment outside the submitted work. Mss Morales and Aguilar and Drs Truty, Callis, Esplin, Haverfield, Rojahn, and Vatta hold stock from Invitae as employees during the conduct of the study. Supervision: Sturm, Esplin, Garcia, Morales, Nussbaum.Ĭonflict of Interest Disclosures: Ms Sturm reports that Invitae provides chatbot and genetic testing services for her National Heart, Lung, and Blood Institute–funded grant. Ms Sturm and Dr Rader had access to all variant data that support this study.Ĭoncept and design: Truty, Callis, Esplin.Īcquisition, analysis, or interpretation of data: Sturm, Truty, Callis, Aguilar, Garcia, Haverfield, Morales, Nussbaum, Rojahn, Vatta, Rader.ĭrafting of the manuscript: Morales, Rojahn.Ĭritical revision of the manuscript for important intellectual content: All authors.Īdministrative, technical, or material support: Sturm, Callis, Aguilar, Haverfield, Morales, Nussbaum, Rojahn. JAMA Cardiology.Īuthor Contributions: Dr Truty had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Open Access: This is an open access article distributed under the terms of the CC-BY-NC-ND License. Sturm, MS, Genomic Medicine Institute, Geisinger, Weis Center for Research, 100 N Academy Ave, Danville, PA 17822 ( for Publication: March 25, 2021.
0 Comments
Leave a Reply. |